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Abstract
Background: An accurate estimate of the total number of cases and severity of illness of an emerging infectious disease is
required both to define the burden of the epidemic and to determine the severity of disease. When a novel pathogen first
appears, affected individuals with severe symptoms are more likely to be diagnosed. Accordingly, the total number of cases
will be underestimated and disease severity overestimated. This problem is manifest in the current epidemic of novel
influenza A/H1N1.
Methods and Results: We used a simple approach to leverage measures of incident influenza A/H1N1 among a relatively
small and well observed group of US, UK, Spanish and Canadian travelers who had visited Mexico to estimate the incidence
among a much larger and less well surveyed population of Mexican residents. We estimate that a minimum of 113,000 to
375,000 cases of novel influenza A/H1N1 have occurred in Mexicans during the month of April, 2009. Such an estimate
serves as a lower bound because it does not account for underreporting of cases in travelers or for nonrandom mixing
between Mexican residents and visitors, which together could increase the estimates by more than an order of magnitude.
Conclusions: We find that the number of cases in Mexican residents may exceed the number of confirmed cases by two to
three orders of magnitude. While the extent of disease spread is greater than previously appreciated, our estimate suggests
that severe disease is uncommon since the total number of cases is likely to be much larger than those of confirmed cases.
Citation: Lipsitch M, Lajous M, O’Hagan JJ, Cohen T, Miller JC, et al. (2009) Use of Cumulative Incidence of Novel Influenza A/H1N1 in Foreign Travelers to
Estimate Lower Bounds on Cumulative Incidence in Mexico. PLoS ONE 4(9): e6895. doi:10.1371/journal.pone.0006895
Editor: Alison P. Galvani, Yale University, United States of America
Received May 21, 2009; Accepted July 27, 2009; Published September 9, 2009
Copyright:  2009 Lipsitch et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the US National Institutes of Health cooperative agreement 5U01GM076497 ‘‘Models of Infectious Disease Agent Study’’
(M.Lipsitch, J.O’H. and E.G.), the Mexican National Council for Science and Technology (CONACyT), the Ministry of Health of Mexico (M.Lajous) and the Department
of Epidemiology, Harvard School of Public Health (M.Lajous and J.O’H.), the RAPIDD program of the Science & Technology Directorate, Department of Homeland
Security, and the Fogarty International Center, National Institutes of Health (J.C.M.), the Medical Research Council, UK (L.D.) and the Research Fund for The Control
of Infectious Disease of the Government of the Special Administrative Region of Hong Kong, and NIH R01 TW008246-01 from the Ecology of Infectious Disease
program (SR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: ML has received compensation for consulting for the Avian/Pandemic Flu Registry, funded in part by Roche.
* E-mail: mlipsitc@hsph.harvard.edu
Introduction
A reliable estimate of the cumulative number of infections for an
emerging disease, such as novel influenza A/H1N1, is critical to
determine both the magnitude of the problem and the severity of
disease. Cumulative incidence is the most direct estimate of the
magnitude of the epidemic, while cumulative deaths and
hospitalizations must be divided by cumulative incidence (with
appropriate correction for reporting delays and censoring [1]) to
estimate the probability of severe outcomes for individuals that
become infected. While critical for situational awareness, cumu-
lative incidence is often difficult to measure in a large epidemic,
because often there is a bias toward ascertainment of severe cases.
Where underreporting of asymptomatic and mild cases,
especially those that do not present for medical care, is likely,
there is a need for nonstandard approaches to estimate the
magnitude of the epidemic and severity of disease. Here we
propose and apply such a method to estimate the number of cases
of novel influenza A/H1N1 in Mexico up to approximately April
30, 2009, based on the number of cases observed in foreign
travelers. Intuitively, the notion is that such travelers act as
‘‘canaries in the mine’’ who briefly experience the daily risk of
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infection prevalent in Mexico during their visit, then return home
to areas where, given the elevated level of concern, they may be
detected as cases of novel H1N1, even if not severe. By assuming
(conservatively) that the risk of infection experienced by Mexicans
is at least equal to that experienced by visitors, and using travel
data to assess the amount of person-time at risk for visitors, we
estimate the incidence rate in proportion to the Mexican
population, and estimate a lower-bound of how many cases may
have been present in Mexico at a defined time.
Here we estimate that at least 113,000–375,000 cases of novel
H1N1 influenza occurred in Mexicans before the end of April,
2009. We discuss the uncertainties associated with this estimate
and present our rationale for why this number represents a lower
bound for the true number. Finally, we discuss the implications for
estimating the case-fatality proportion of this infection in Mexico.
Results
Baseline estimate
We estimate that approximately 375,000 Mexicans were
infected with novel H1N1 influenza with symptom onset up to
approximately April 30, 2009. This estimate derives from 283
cases among US, UK, Spanish and Canadian travelers, counting
confirmed and probable cases for the US and confirmed cases only
for the other two countries. Citizens of these countries together
accounted for approximately 689,250 airplane passenger visits to
Mexico in the period April 1–30, 2009, and international visitors
to Mexico had a mean length of stay of approximately 3.5 days, for
a total of 2.4 million person-days of exposure during this period
(Table 1). This implies that visitors experienced an incidence rate
of 91 cases per million person-days at risk. In the same period, the
Mexican population of approximately 107 million persons had
306107 million, or 3.2 billion person-days of exposure.
Sensitivity analysis: unknown travel history
Travel history was known for 49% (929/1890) of US confirmed
cases and 48% (86/179) of Canadian confirmed cases, 97% (37/
38) of the UK cases and 100% (93/93) of Spanish cases. If the
proportion of cases with travel history to Mexico is assumed to be
the same for those with missing data in this field, the imputed
number of total cases with travel history would rise to 418, and the
implied number of cases in Mexicans would rise to 554,000. We
strongly suspect that travel history is more likely to be known in
those who did travel to Mexico than in those who did not, which
would suggest that the correction for missing travel history should
be somewhat less than assumed here. We therefore do not include
this large estimate in our overall range of estimates.
Sensitivity analysis: possible clusters among travelers,
and border state cases
Several cases among travelers may have resulted from clusters of
exposure and/or from transmission within the traveling group. In
order to exclude the effects of transmission among travelers or
cases of disease imported by means other than air travel, we
provide a revised estimate calculated from a subset of 228 cases.
This reduced number of cases excludes both secondary cases
within putative clusters of travelers (these data were available for
travelers from each country except Spain) and excludes US cases
residing in or south of the closest major city to the Mexican border
who may have visited by means other than air travel. This
approach yields an estimate of 302,000 cases in Mexicans;
additional correction for clustering in Spanish cases, if the
required data were available, would further reduce this figure.
Sensitivity analysis: length of stay
For reasons discussed below, we believe that 3.5 days is an
appropriate estimate for the mean duration of stay in Mexico for
all visitors, which heavily weights US visitors because the US is the
largest source of visitors. However, given that one study suggests a
considerably longer length of stay [2], and that non-US visitors
likely stay longer given the longer trip involved, we performed a
sensitivity analysis assuming that visitors from the US, Canada and
European countries have lengths of stay of 8.7, 10.5, and 13.9 days
respectively, using numbers from an unpublished 2008 update of
the 2001–5 survey (Gerardo Vazquez, Mexico Ministry of
Tourism, personal communication). Using the data with possible
clusters and near-border cases removed, produces a low estimate
of 113,000 cases in Mexican residents.
Sensitivity analysis: non-homogeneous disease across
Mexico
This analysis assumes that incidence during April was
homogeneous across 107 million Mexicans. If the rates of disease
among Mexicans in travel destinations was higher or lower than
elsewhere, this might substantially alter these estimates. The
national cumulative incidence of suspect cases as of May 9 was
17.32/100,000, which was 16x higher than that in Puebla, the
state with the lowest incidence, and 4x lower than that in Distrito
Federal, the capital, with the highest reported incidence. Quintana
Roo, the state containing Cancun, which is the most popular
Table 1. Cases of novel influenza A/H1N1 among travelers to Mexico from three countries as of May 6, 2009 (Canada) or May 8,
2009 (US, UK, Spain) and associated estimates.
US (confirmed+probable) Canada (confirmed) UK (confirmed) Spain (confirmed) Total
Cases with Mexico travel history 132 62 19 70 283
Cases with travel history known/total cases 928/1890 86/179 37/38 93/93
With only one case per possible cluster, and
near border cases removed
85 56 17 no data to assess
clusters; 70 assumed
228
Travel volume for April 526,861 119,473 22,013 20,903 668,347
Inferred incidence rate (/million person-days) 72 148 246 957 117
Inferred cases in Mexico 229,000 475,000 789,000 3,062,000 375,000
Inferred incidence rate (/million person-days)* 18 44 55 241 35
Inferred cases in Mexico* 59,000 142,000 178,000 771,000 113,000
doi:10.1371/journal.pone.0006895.t001
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single destination for travelers from these countries, reported
incidence of 12.10/100,000. If these incidence numbers reflect
true incidence variation in the country (which is unlikely to be the
only source of variation), then total Mexican incidence should be
1.4 times higher than that estimated from Cancun travelers, or 4x
lower than that estimated for Mexico City travelers. Unfortunate-
ly, destination data are not available for the majority of travel-
associated cases in any of the four countries we considered.
Discussion
We have estimated that there are likely to have been at least
113,000–375,000 cases of novel H1N1 influenza among Mexicans
with onset during the month of April, 2009. Taking into account what
we consider to be extreme sensitivity analyses, this estimate could
change by approximately 2-fold in either direction. This exceeds the
number of confirmed cases reported to WHO, 1204 as of May 8, 2009
(http://www.who.int/csr/don/GlobalSubnationalMaster_20090508_
1815.jpg), by a factor of approximately 100 or more.
It is unsurprising that we estimate a larger number than the
number of cases confirmed in Mexico, since ascertainment there
has been particularly focused on severe cases. Nevertheless, we
regard this estimate as likely a lower bound on the actual number
of cases in Mexico, for two principal reasons. First, the analytic
approach assumes that the incidence rate in Mexicans in Mexico is
equal to that in travelers. If indeed the infection has been
transmitting extensively within Mexico, one would expect that the
exposure of travelers to the virus would be somewhat less than that
of residents, due to nonrandom mixing between residents and
travelers; travelers should be less exposed to residents than other
residents are. Prior models of influenza transmission (set in the
United States) have assumed that 36–51% of influenza transmis-
sion takes place outside of home or school [3]. One might roughly
estimate that this is the proportion of transmission to which both
visitors and residents would be exposed, suggesting that incidence
in residents might be 2–3x as high as that in visitors; however, this
approach has obvious limitations given the uncertainty of those
estimates and the fact that they were made for a different country.
Second, while most cases ascertained in the traveler population
to date have been mild, one nonetheless expects that many mild
cases (as well as probable but unconfirmed cases) in travelers are
absent from our calculations. A survey in New York City, where
case ascertainment was aggressive surrounding the St. Francis
School outbreak, indicated that over 1000 persons associated with
the school experienced influenza-like illness, in a period where
only 74 confirmed or probable cases were ascertained. If these
figures reflect the typical rate of under-reporting in the United
States, then the inferred figures from Mexico should increase by
.1000/74 = 14-fold. Likewise, any foreign residents who became
ill in Mexico (rather than in their home country) may have been
missed in our counts of travelers. In essence, the method used here
is a way to estimate cases in a population where they are likely
being undercounted, based on travelers to countries in which
undercounting, though present, is less severe. Since the inferred
number of cases in Mexican residents scales linearly with the
number observed in travelers, the number in Mexican residents is
likely to be considerably higher than we have estimated.
Forty-eight deaths were observed up to May 9 among
laboratory-confirmed cases in Mexico [4]. While it might be
tempting to calculate a case-fatality proportion by dividing this
number by the estimated number of cases in Mexico, such a
calculation would likely be misleading, for several reasons. In a
growing epidemic, given a significant delay from illness onset to
death [5], one expects to underestimate the case-fatality
proportion as the deaths reflect cases from an earlier, smaller
phase of the epidemic [6]. Also, counting only laboratory
confirmed deaths is likely to result in a significant underestimation
of the true number of deaths, because of insensitivity depending on
the timing and adequacy of the specimen, the fact that many
severe pneumonia patients were not tested (approximately 1000–
2000 such cases typically occur in Mexico in April [7]), and the
fact that a majority of influenza deaths are attributed to circulatory
causes rather than identified as pneumonia or influenza [8].
Nonetheless, as the number of deaths accumulates, especially if
illness onset dates are available for fatal cases, our estimates may
provide an appropriate denominator for revised estimates of the
case-fatality proportion. The number of hospitalizations associated
with suspect cases was 6,754 as of May 9 [4], which combines with
our denominator to give a hospitalization proportion of about 2%,
closer to figures observed elsewhere.
We have shown in Table 1 the estimates obtained using only
travelers from each country individually. Here, the US-based
estimates are the lowest, with greater estimates from those based
on Canadians and still greater estimates based on Europeans. In
part this may reflect a longer duration of trips for travelers from
more distant destinations, but even using the destination-specific
duration data does not remove this effect. As we note below, we
cannot rule out the possibility that some transmission occurred on
airplanes; such transmission might be more likely in travelers flying
longer distances. Differences in patterns of exposure within
Mexico, chance variation and other factors must account for the
remaining differences.
This simple model has several principal limitations. First, we do
not incorporate exposure of travelers who arrive by ship or
overland, only by air. While we have excluded from the numerator
the one traveler case with a known cruise ship exposure, we may
have slightly overestimated the incidence in travelers by neglecting
such exposures. Second, our calculations make the assumption that
incidence is uniform geographically throughout Mexico and across
age group. All but one state in Mexico have now reported cases
(http://portal.salud.gob.mx/sites/salud/descargas/pdf/influenza/
situacion_actual070511.pdf), and all have at least suspect cases [3],
so it is likely reasonable to assume that persons throughout Mexico
were exposed to some extent. However, the exposure may not have
been uniform. This may be a further reason to consider our estimate
as a lower bound, since the detected cases are heavily concentrated
in the State of Mexico and the Distrito Federal, the destination of
,18% of visitors from these countries, while the most popular
airport of entry for visitors from the US, UK and Canada in April
2009 was Cancun, which accounted for 47.5%–74.5% of visitors for
each nationality but had relatively low reported incidence. As the
pandemic has evolved, it has become clear that different age groups
experience different risks of confirmed and probable infection with
the pandemic virus, with the highest rates of confirmed and
probable infection among persons under 25 years old (http://www.
cdc.gov/h1n1flu/surveillanceqa.htm). Finally, we assume that
transmission to travelers occurred in Mexico, not on an aircraft.
An influenza outbreak on an aircraft has been documented [9], and
if a cluster of such infections were included in our numbers, it would
result in an overestimate of incidence in Mexico. Notably, 36% of
travel-associated cases in Spain for whom data were available were
symptomatic during the inbound flight; given the incubation period
of influenza, these travelers, at least, could not plausibly have
become infected during the flight [10].
Our estimates of cases are larger, by about 10-fold, than those
reported by Fraser et al. [11]. Importantly, this reflects the fact
that we base ascertainment on numbers available on May 6–8,
while Fraser et al. base ascertainment on numbers available on
H1N1 Incidence in Mexico
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April 30. With rapid epidemic growth, the difference of one week
is likely to account for a difference of perhaps 2-8-fold. Also, Fraser
et al. use a longer mean length of stay (9 days) and a larger travel
volume. Estimates of the length of stay cited by Fraser et al. [11]
were close to 9 days in 2001-5 [2], and we have considered a
sensitivity analysis based on an updated version of that survey,
using numbers specific to origin of the travelers. For our primary
analysis, however, we used figures from the Ministry of Tourism
indicating a mean length of stay of 3.4 days (see Methods), while
an independent study conducted by the National Association of
Hotels and Motels finds a similar value of 3.6 days for the mean
length of hotel stay by foreign visitors, and a very recent survey
found that the majority of US leisure travelers interested in visiting
Mexico take vacations for 4 nights or less (personal communica-
tion). Our travel volumes are lower in part because we have used
citizenship rather than first destination outside Mexico (to better
reflect likely final destination) and have used data on number of
incoming passengers (corrected to estimate outgoing passengers)
rather than flight data, which may perhaps reflect capacities rather
than actual numbers. Altogether, these differences in data sources
could account for approximately a 3-fold variation in estimates,
apart from the variation due to different time periods considered.
Accurate estimation of the magnitude of an emerging epidemic
is essential for maintaining situational awareness and determining
a rational public health response. The simple approach applied
here indicates that the likely number of cases of H1N1 influenza
among Mexican residents during the month of April, 2009 was at
least two orders of magnitude larger than that detected. While
such calculations should not be interpreted as precise estimates of
cumulative incidence, they provide important perspective in
interpreting data from detected cases in situations where extensive
surveillance is unlikely to occur.
Methods
Data sources
Cases in travelers. Cases ascertained in the US in travelers
were obtained from the US CDC line list dated May 8 at 0100
EDT, reflecting cases reported up to May 7. Possible clusters of
traveler cases were detected by manual scan of the line list for cases
with common county of report, closely related onset dates, and no
indication that they lived in different households. Cases
ascertained in Canada in travelers were obtained from a copy of
the Canadian line list dated May 6 residing at the US CDC.
Possible clusters of traveler cases were noted on the line list itself.
Cases ascertained in the UK in travelers were obtained from a
comprehensive scan of press reports cross-checked with UK
Health Protection Agency daily updates to ensure consistency of
numbers, and possible clusters were ascertained the same way.
One case from the United States known to be in a woman visiting
Mexico on a cruise ship was excluded since cruise ship visitors
were not included in our travel estimates. The number of cases in
travelers was denoted U . Use of line lists from 6–8 days after our
period of interest was selected because for those entering the US
CDC line list, the mean delay from symptom onset was 7 days.
Hence, the US data, which represented the majority of cases,
should be representative of cases with onset in the period up to
April 30. The number of cases from Spain was taken from the
recent report produced by the Surveillance Group in Spain [10].
Person-time at risk
The Mexican population was assumed to be PM = 106,682,518
persons as estimated by the National Council for Population
of Mexico http://www.conapo.gob.mx/index.php?option = com_
content&view = article&id = 125&Itemid = 193. Estimates of the
number of travelers returning from Mexico during the period
April 1–30 were obtained using data from Mexican immigration
records deposited in the Sistema Integral de Operacio´n Migratoria
(SIOM). This database contains information on the citizenship of
all travelers arriving into Mexican airports. Assuming that the
populations of inbound and outbound travelers from Mexico are
in near-steady state the number of inbound travelers should give a
reliable estimate of the number of outbound travelers. Records
were abstracted for the period April 1–30. Note that our method is
not strongly sensitive to the exact period considered, since
additional days would proportionately increase the person-time
for Mexican residents and approximately proportionately increase
the person-time for visitors. We did not decrement the person-time
to account for time no longer at risk once a Mexican resident was
infected.
The number of Canadian, British and Spanish travelers arriving
into Mexico began to drop off on April 27th, likely in response to
the media coverage of the outbreak, while the number of US
travelers to Mexico began to decrease on April 26th. As it is
unlikely that the number of outbound travelers decreased over this
period we calculated the average number of travelers arriving into
Mexico for each day of the week using data for the first three
weeks of April. These estimates were used instead of the actual
daily numbers of travelers for the latter days of April. The total
number of travelers into Mexico was denoted Pt. The mean
duration of stay was assumed to be D~3.5 days. This was based
on a mean stay of 3.6 days from survey data for hotel stays in April
2009 from the National Association of Hotels and Motels of
Mexico (personal communication) and on a mean stay of 3.4 days
from survey data posted by the Mexican Tourism Ministry
(http://www.sectur.gob.mx/wb/secturing/sect_8978_study_of__
tourist_pr). In addition, a survey of a representative sample of US
leisure travelers interested in visiting Mexico conducted in
February and March of 2009 found that 74% of all vacations
taken by this group were 4 nights or less (P. Yesawich, National
Leisure Travel Monitor, personal communication).
Alternative estimates obtained from a 2008 Bank of Mexico
tourism survey (Gerardo Vazquez, Mexico Ministry of Tourism,
personal communication) an earlier version of which was used by
Fraser et al. [11] give longer durations of stay overall and indicate
heterogeneity by nationality in length of stay: 8.7 nights for US
citizens, 10.5 nights for Canadians and 13.9 nights for others.
These estimates were used in a sensitivity analysis. We note that
with a typical incubation period of about 1–2 days for influenza A
[13], individuals infected early on in a stay of two weeks would
have been sick for a week or more before returning home, at which
point they might have stopped shedding detectable virus. Our
estimates are based on infections confirmed in the country to
which a traveler returned, and would therefore tend to miss many
such infections, suggesting that only a fraction of such a long stay
would be ‘‘at risk’’ for the event of infection detected upon return.
Analysis
If the incidence rate in Mexicans were x times that in visitors,
then the following equality should hold, relating the incidence rate
in each population: x U
DPt
~ M
30PM
, where in the month of April
each Mexican had 30 days at risk, and each visitor had D days at
risk on average. Estimates for each quantity except for M, the
unknown number of incident cases in Mexican residents, were
provided from data, under the conservative assumption that x~1,
and the equation was solved for M. The major statistical
uncertainty in our estimates comes from the number of visitors
who were infected, which as a count with a value of 283 should
H1N1 Incidence in Mexico
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have a coefficient of variation of 6%, negligible compared to the
uncertainties of underreporting and differences in exposure of the
visitor and resident populations. For this reason, statistical
uncertainty was not explicitly quantified in our estimates.
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